RHEUMATOLOGY

Bruce Rothschild, MD, on Antiphospholipid Antibodies for the Safety of JAK Inhibitors

08/01/2019

Bruce Rothschild, MD, from Indiana University Ball Memorial Hospital, discusses the concerns of JAK inhibitor use, how rheumatologists can use antiphospholipid antibodies as an indication of thrombotic events, the importance of monitoring medications for safety, and more.

Bruce Rothschild, MD, is a clinical professor at Indiana University Ball Memorial Hospital in Muncie, Indiana.

Stay in the Know

Rheumatology & Arthritis Newsletter

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1

Popular Articles

RHEUMATOLOGY

Christine Peoples, MD, on Telemedicine`s Role in a Long-Term Patient-Provider Relationship

06/10/2019

Christine Peoples, MD, from University of Pittsburgh Medical Center, discusses telemedicine in a rheumatology setting, its impact on care amidst the shortage of rheumatologists, and more.

Christine Peoples, MD, from...

06/10/2019

Rheumatology & Arthritis

FDA Approves First Treatment for Certain Inflammatory Arthritis

03/28/2019

The US Food and Drug Administration has approved Cimzia (certolizumab pegol) injection for the treatment of adults with non-radiographic axial spondyloarthritis with objective signs of inflammation. The approval comes...

The US...

03/28/2019

Rheumatology & Arthritis

In RA, Immunosuppressant Can Lower Cardiovascular Event Risk

12/13/2018

Individuals with rheumatoid arthritis (RA) who continuously use methotrexate have a 20% decrease in risk for cardiovascular events, according to a new study.   To reach this conclusion, the researchers analyzed...

...

12/13/2018

Rheumatology & Arthritis

In AS, Anti-TNF-α Therapy Can Restore Microvascular Function

10/02/2018

Anti-tumor necrosis factor-α (Anti-TNF- α) inhibitor therapy can replenish microcirculation function and capillary edema in patients with ankylosing spondylitis (AS), according to recent findings.  The research...

...

10/02/2018

Rheumatology & Arthritis

Probenecid vs Allopurinol for CV Risk in Gout Patients

02/27/2018

Probenecid use is associated with a modest decrease in the risk of cardiovascular (CV) events in elderly patients with gout, according to a recent study. For their study, the researchers assessed 38,888 gout patients...

...

02/27/2018

Rheumatology & Arthritis

Bruce Rothschild, MD, on Antiphospholipid Antibodies for the Safety of JAK Inhibitors

Stay in the Know

Partner Spotlight

Popular Articles

Specialties

Events

Year Round Education

HMP Global Products